Zobrazeno 1 - 10
of 112
pro vyhledávání: '"JM Hows"'
Publikováno v:
Blood. 75:1728-1732
From April, 1985, to February, 1989, 102 consecutive patients received unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia (CML) at four centers. Median age of the group was 31 years (range, 4.5 to 51 years). Fifty-fo
Autor:
Jo, Cullis, Rm, Szydlo, Nc, Cross, Di, Marks, Ap, Schwarer, Tp, Hughes, Mackinnon S, Geoff Hale, Waldmann H, Jm, Hows
Publikováno v:
Europe PubMed Central
Between January 1985 and March 1992, 48 patients with chronic phase CML underwent BMT from volunteer unrelated donors (MUD) serologically identical at HLA-A, B and DR loci. 19 patients received donor marrow ex vivo T-cell depleted (EX-TCD) with Campa
Autor:
JC Marsh, AJ Will, JM Hows, P Sartori, PJ Darbyshire, PJ Williamson, DG Oscier, TM Dexter, NG Testa
Publikováno v:
Blood. 79(12)
We have used the long-term bone marrow culture (LTBMC) system to analyze hematopoiesis in three patients with dyskeratosis congenita (DC), two of whom had aplastic anemia, and the third had a normal blood count (apart from mild macrocytosis) and norm
Autor:
E Gluckman, MM Horowitz, RE Champlin, JM Hows, A Bacigalupo, JC Biggs, BM Camitta, RP Gale, EC Gordon-Smith, AM Marmont
Publikováno v:
Blood. 79(1)
Data for 595 patients with severe aplastic anemia receiving HLA- identical sibling bone marrow transplants were analyzed to determine the effect of pretransplant conditioning and graft-versus-host disease (GVHD) prophylaxis on outcome. Transplants we
Publikováno v:
Blood. 76(10)
We studied the in vitro effects of lymphokine-activated killer (LAK) cells from the peripheral blood of chronic myeloid leukemia (CML) patients after allogeneic and syngeneic bone marrow transplantation (BMT). LAK cells were generated by incubating p
Publikováno v:
Blood. 70(4)
Sixty-four patients with aplastic anemia were treated with antilymphocyte globulin (ALG Merieux) between 1980 and 1985. The actuarial survival for all patients was 53% at 6 years, with 79% survival for nonsevere aplastic anemia (NSAA) and 36% for sev
Autor:
Spencer A, Rm, Szydlo, Pa, Brookes, Kaminski E, Rule S, van Rhee F, Kn, Ward, Geoff Hale, Waldmann H, Jm, Hows, Jr, Batchelor, Jm, Goldman
Publikováno v:
Europe PubMed Central
Between August 1985 and July 1994, we performed 115 volunteer unrelated donor (VUD) bone marrow transplants (BMT) for first chronic phase (n = 86) or advanced phase (n = 29) chronic myeloid leukemia (CML). Standard serologic HLA typing of potential d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ea9ec2b3c50e56604a37180c24450a68
http://europepmc.org/abstract/med/7579468
http://europepmc.org/abstract/med/7579468
Autor:
Grey-Davies E; Department of Haematology, St George's Hospital, London, UK. lizgreydavies@doctors.net.uk, Hows JM, Marsh JC
Publikováno v:
British journal of haematology [Br J Haematol] 2008 Oct; Vol. 143 (2), pp. 258-60. Date of Electronic Publication: 2008 Aug 10.
Autor:
Panepinto JA; Department of Hematology/Oncology/Bone Marrow Transplant, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA. jpanepin@mcw.edu, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale RP, Hale GA, Horan J, Hows JM, Klein JP, Pasquini R, Roberts I, Sullivan K, Eapen M, Ferster A
Publikováno v:
British journal of haematology [Br J Haematol] 2007 Jun; Vol. 137 (5), pp. 479-85. Date of Electronic Publication: 2007 Apr 24.
Autor:
Hows JM; Department of Biomedical Sciences, Faculty of Applied Sciences, University of the West of England, Bristol, UK. jill.hows@bristol.ac.uk, Passweg JR, Tichelli A, Locasciulli A, Szydlo R, Bacigalupo A, Jacobson N, Ljungman P, Cornish J, Nunn A, Bradley B, Socié G
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2006 Dec; Vol. 38 (12), pp. 799-805. Date of Electronic Publication: 2006 Oct 30.